In this issue
Evidence Resources
Dealing with synthetics: time to reframe the narrative.
Buxton, Julia and Bewley-Taylor, Dave and Hallam, Christopher . (2017) Dealing with synthetics: time to reframe the narrative. Swansea: Global Drug Policy Observatory. 49 p. Policy report 6
read more »
Psychoactive substances in secure mental health settings.
Smith, Sarah and Day, Matt and Maddalena, Nino [Public Health England] . (2017) Psychoactive substances in secure mental health settings. London: Public Health England. 53 p.
read more »
Do we all agree what "good health care" looks like? Views from those who are "seldom heard" in health research, policy and service improvement.
Ryan, Sara and Hislop, Jenny and Ziebland, Sue . (2017) Do we all agree what "good health care" looks like? Views from those who are "seldom heard" in health research, policy and service improvement. Wiley. Health Expectations, 20 (5)
read more »
Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations.
Kaner, Eileen et al [The Cochrane Library] . (2017) Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations. London: John Wiley & Sons, Ltd. Cochrane Database of Systematic Reviews DOI: 10.1002/14651858.CD011479.pub2
read more »
The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review.
Nugent, Shannon M and Morasco, Benjamin J and O'Neil, Maya E and Freeman, Michele and Low, Allison and Kondo, Karli and Elven, Camille and Zakher, Bernadette and Motu'apuaka, Makalapua and Paynter, Robin and Kansagara, Devan . (2017) The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review. American College of Physicians. Annals of Internal Medicine, 167 (5)
read more »
Serotonin and brain function: a tale of two receptors.
Carhart-Harris, RL and Nutt, DJ . (2017) Serotonin and brain function: a tale of two receptors. Sage. Journal of Psychopharmacology, 31 (9)
read more »
Policy in action. A tool for measuring alcohol policy implementation.
World Health Organization Regional Office for Europe. (2017) Policy in action. A tool for measuring alcohol policy implementation. Copenhagen: World Health Organization Regional Office for Europe. 61 p.
read more »
Preventing the violent and sexual victimisation of vulnerable gang-involved and gang-affected children and young people in Ipswich.
Andell, Paul and Pitts, John . (2017) Preventing the violent and sexual victimisation of vulnerable gang-involved and gang-affected children and young people in Ipswich. Suffolk: University of Suffolk. 70 p.
read more »
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.
Schuit, Ewoud and Panagiotou, Orestis A and Munafo, Marcus R and Bennett, Derrick A and Bergen, Andrew W and David, Sean P [The Cochrane Library] . (2017) Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. London: John Wiley & Sons, Ltd. Cochrane Database of Systematic Reviews (9) DOI: 10.1002/14651858.CD011823.pub2
read more »
Models of delivery for stop smoking services. Options and evidence.
Public Health England. (2017) Models of delivery for stop smoking services. Options and evidence. London: Public Health England. 17 p,.
read more »
Effect of tobacco control policies on perinatal and child health: a systematic review and meta-analysis.
Faber, Timor and Kumar, Arun and Mackenbach, Johan P and Millett, Christopher and Basu, Sanjay and Sheikh, Aziz and Been, Jasper V . (2017) Effect of tobacco control policies on perinatal and child health: a systematic review and meta-analysis. Elsevier. The Lancet, 2 (9)
read more »
Internet-based interventions for smoking cessation
Taylor, Gemma MJ and Dalili, Michael N and Sernwal, Monika and Civljak, Marta and Sheikh, Aziz and Car, Josip [The Cochrane Library] (2017) Internet-based interventions for smoking cessation. London: John Wiley & Sons, Ltd. Cochrane Database of Systematic Reviews (9) DOI: 10.1002/14651858.CD007078.pub5
read more
Healthcare financing systems for increasing the use of tobacco dependence treatment.
van den Brand, Floor A and Nagelhout, Gera E and Reda, Ayalu A and Winkens, Bjorn and Evers, Silvia MAA and Kotz, Daniel [The Cochrane Library] (2017) Healthcare financing systems for increasing the use of tobacco dependence treatment. London: John Wiley & Sons, Ltd. Cochrane Database of Systematic Reviews, 9  DOI: 10.1002/14651858.CD004305.pub4
read more
The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations.
Mdege, Noreen D and Meader, Nick and Llyod, C and Parrott, Steve and McCambridge, Jim . (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research, 5 (4)
read more »
EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB).
European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB). Luxembourg: Joint Reports, Publications Office of the European Union. 16 p.
read more »
EMCDDA–Europol Joint Report on a new psychoactive substance: N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF).
European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF). Luxembourg: Joint Reports, Publications Office of the European Union. 14 p.
read more »
EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA).
(2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA). Luxembourg: Joint Reports, Publications Office of the European Union. 19 p.
read more »
EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide (tetrahydrofuranylfentanyl; THF-F).
European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide (tetrahydrofuranylfentanyl; THF-F). Luxembourg: Joint Reports, Publications Office of the European Union. 13 p.
read more »
EMCDDA–Europol Joint Report on a new psychoactive substance: 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA).
[European Monitoring Centre for Drugs and Drug Addiction] (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA). Luxembourg: Joint Reports, Publications Office of the European Union. 15 p.
read more »
EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA).
European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). Luxembourg: Joint Reports, Publications Office of the European Union. 15 p.
read more »